Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety and Performance of the Zilver® PTX™ Drug-Eluting Stent for Treating De Novo or Restenotic Lesions of the Above-the-knee Femoropopliteal Artery

NCT01094678 is registered in ClinicalTrials.gov with Cook Group Incorporated as lead sponsor.

NCT NCT01094678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01094678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety and Performance of the Zilver® PTX™ Drug-Eluting Stent for Treating De Novo or Restenotic Lesions of the Above-the-knee Femoropopliteal Artery
Lead sponsor
Cook Group Incorporated
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2006
Completion date
April 30, 2011
Enrollment
788 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial disease, peripheral vascular disease